A summary of the biological activities obtained for the third set of compounds in 2012 - those arising from the consultation for which synthetic and commercial compounds that were most wanted. See also some links for analysis of trends in the data.
Second set (Nov 8th) Data, and discussion
Third set (Dec 10) Data (essentially inactive, aside from mild activity for OSM-S-103
Previous discussion of these data, highlighting trends.